Literature DB >> 3510440

Axillary lymph node metastases in breast cancer: preoperative detection with US.

J N Bruneton, E Caramella, M Héry, D Aubanel, J J Manzino, J L Picard.   

Abstract

The importance of axillary node status in the prognosis of breast cancer led the authors to conduct a prospective study comparing the value of clinical examination with ultrasound (US) performed by a transpectoral approach. All 60 patients examined underwent axillary dissection. Sensitivity was 45.4% for clinical examination versus 72.7% for US. US provides valuable information for breast cancers treated solely by irradiation, after insufficient dissection, and for large tumors not amenable to primary surgery. When the nodal region is treated by surgery and/or radiotherapy, local monitoring with US appears unnecessary owing to the low incidence of nodal recurrence.

Entities:  

Mesh:

Year:  1986        PMID: 3510440     DOI: 10.1148/radiology.158.2.3510440

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  24 in total

1.  Role of ultrasound in the preoperative staging of patients with breast cancer.

Authors:  Maja Podkrajsek; Maja Marolt Music; Maksimiljan Kadivec; Janez Zgajnar; Nikola Besic; Ana Pogacnik; Marko Hocevar
Journal:  Eur Radiol       Date:  2005-01-27       Impact factor: 5.315

2.  Utility of Preoperative Staging of Ipsilateral Axilla with Ultrasound and Guided Needle Aspiration in Early-Stage Breast Cancer-Current Indian Scenario.

Authors:  Balasubramanian Venkitaraman; Kajamohideen Suhailudeen
Journal:  Indian J Surg Oncol       Date:  2018-07-26

3.  Detection of axillary lymph node metastases in breast carcinoma by technetium-99m sestamibi breast scintigraphy, ultrasound and conventional mammography.

Authors:  W W Lam; W T Yang; Y L Chan; I E Stewart; C Metreweli; W King
Journal:  Eur J Nucl Med       Date:  1996-05

4.  To Evaluate the Accuracy of Axillary Staging Using Ultrasound and Ultrasound-Guided Fine-Needle Aspiration Cytology (USG-FNAC) in Early Breast Cancer Patients-a Prospective Study.

Authors:  Rashpal Singh; S V S Deo; Ekta Dhamija; Sandeep Mathur; Sanjay Thulkar
Journal:  Indian J Surg Oncol       Date:  2020-10-19

Review 5.  Accuracy of axillary ultrasound in the diagnosis of nodal metastasis in invasive breast cancer: a review.

Authors:  Jonathan Cools-Lartigue; Sarkis Meterissian
Journal:  World J Surg       Date:  2012-01       Impact factor: 3.352

Review 6.  Axillary lymph node echo-guided fine-needle aspiration cytology enables breast cancer patients to avoid a sentinel lymph node biopsy. Preliminary experience and a review of the literature.

Authors:  Vittorio Altomare; Gabriella Guerriero; Rita Carino; Cleonice Battista; Angelo Primavera; Annamaria Altomare; Donata Vaccaro; Alessandro Esposito; Anna Maria Ferri; Carla Rabitti
Journal:  Surg Today       Date:  2007-08-27       Impact factor: 2.549

7.  Staging of the axilla in breast cancer: accurate in vivo assessment using positron emission tomography with 2-(fluorine-18)-fluoro-2-deoxy-D-glucose.

Authors:  I C Smith; K N Ogston; P Whitford; F W Smith; P Sharp; M Norton; I D Miller; A K Ah-See; S D Heys; J A Jibril; O Eremin
Journal:  Ann Surg       Date:  1998-08       Impact factor: 12.969

8.  Multiparametric monitoring of tumor response to chemotherapy by noninvasive imaging.

Authors:  Zdravka Medarova; Leonid Rashkovetsky; Pamela Pantazopoulos; Anna Moore
Journal:  Cancer Res       Date:  2009-01-13       Impact factor: 12.701

9.  A comparison between ultrasonography and mammography, computed tomography and digital subtraction angiography for the detection of breast cancers.

Authors:  N Tohnosu; K Okuyama; Y Koide; T Kikuchi; T Awano; H Matsubara; T Sano; H Nakaichi; Y Funami; K Matsushita
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

10.  FDG-PET and other imaging modalities for the evaluation of breast cancer recurrence and metastases: a meta-analysis.

Authors:  LingLing Pan; Yuan Han; XiaoGuang Sun; JianJun Liu; Huang Gang
Journal:  J Cancer Res Clin Oncol       Date:  2010-01-21       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.